Compare DoorDash Inc (DASH) vs GSK plc (GSK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DoorDash Inc vs GSK plc — how do they compare? DoorDash Inc trades at $211.85 (market cap $91.86B), while GSK plc trades at $50.56 (market cap $102.60B). The key difference: DoorDash Inc and GSK plc are close in size by market cap, and GSK plc pays a 3.57% dividend while DoorDash Inc pays none. Which is the better fit depends on your goals.
| DASH | GSK | |
|---|---|---|
Market Cap | $91.86B | $102.60B |
Sector | Consumer Cyclical | Health |
52-Week High | $281.74 | $61.18 |
52-Week Low | $146.60 | $38.22 |
Enterprise Value | $89.82B | $123.04B |
Dividend Yield | — | 3.57% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DoorDash Inc
Founded in 2013 and headquartered in San Francisco, DoorDash is an online food order demand aggregator. Consumers can use its app to order food on-demand for pickup or delivery from merchants mainly in the U.S. The firm provides a marketplace for the merchants to create a presence online, market their offerings, and meet demand by making the offerings available for pickup or delivery. The firm provides similar service to businesses in addition to restaurants, such as grocery, retail, pet supplies, and flowers. At the end of 2020, DoorDash had over 450,000 merchants, 20 million consumers, and over 1 million dashers on its platform. In 2020, the firm generated $24.7 billion in gross order volume (up 207% year over year) and $2.9 billion in revenue (up 226%).
Read more on DASH →About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →
